Relationship between patients' characteristics and efficacy of calcimimetics for primary hyperparathyroidism in the elderly.

Koichiro YamamotoYasuhiro NakanoKazuki TokumasuHiroyuki HondaKou HasegawaAsuka SatoHiroko OgawaMikako ObikaYoshihisa HanayamaFumio Otuska

Published in: Clinical case reports (2022)

Calcimimetic treatment has been reported to be effective for primary hyperparathyroidism (PHPT). Nine elderly PHPT patients who had been treated with calcimimetics were retrospectively analyzed. It was found that calcimimetics can reduce elevated serum calcium levels in elderly PHPT patients with low femoral DEXA %YAM and low urinary cAMP levels.

Keyphrases

middle aged
end stage renal disease
community dwelling
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
replacement therapy